Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Vaillant

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Scientific Reports|March 9, 2017
Nucleic acid-based polymers effective against hepatitis B Virus infection in patients don't harbor immunostimulatory properties in primary isolated liver cellsCatherine Isabell Real, Melanie Werner, Andreas Paul, et al.
Hepatology (Baltimore, Md.)|December 19, 2017
Nucleic acid polymer REP 2139 and nucleos(T)ide analogues act synergistically against chronic hepadnaviral infection in vivo in Pekin ducksJonathan Quinet, Catherine Jamard, Madeleine Burtin, et al.
Journal of Viral Hepatitis|November 20, 2018
Variants of hepatitis B virus surface antigen observed during therapy with nucleic acid polymer REP 2139-Ca have no influence on treatment outcome and its detection by diagnostic assaysHrvoje Mijočević, Hadi Karimzadeh, Judith Seebach, et al.
Virology|November 21, 2007
Inhibition of cellular entry of lymphocytic choriomeningitis virus by amphipathic DNA polymersAndrew M Lee, Jillian M Rojek, Anette Gundersen, et al.
Hepatology Communications|July 17, 2023
Rapid monophasic HBsAg decline during nucleic-acid polymer-based therapy predicts functional cureLeeor Hershkovich, Louis Shekhtman, Michel Bazinet, et al.
Plos One|June 22, 2017
Inhibition of hepatitis B viral entry by nucleic acid polymers in HepaRG cells and primary human hepatocytesClément Guillot, Nora Martel, Françoise Berby, et al.
Antimicrobial Agents and Chemotherapy|May 29, 2008
Amphipathic DNA polymers exhibit antiherpetic activity in vitro and in vivoDavid I Bernstein, Nathalie Goyette, Rhonda Cardin, et al.
Antiviral Research|December 20, 2024
HBV serum RNA kinetics during nucleic acid polymers based therapy predict functional cureLeeor Hershkovich, Scott J Cotler, Louis Shekhtman, et al.
Molecular Therapy. Nucleic Acids|September 18, 2017
Nucleic Acid Polymers with Accelerated Plasma and Tissue Clearance for Chronic Hepatitis B TherapyIngo Roehl, Stephan Seiffert, Celia Brikh, et al.
Journal of Viral Hepatitis|July 20, 2019
Kinetics of hepatitis B surface antigen quasispecies during REP 2139-Ca therapy in HBeAg-positive chronic HBV infectionZainab Usman, Hrvoje Mijočević, Hadi Karimzadeh, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Scientific Reports|March 9, 2017
Nucleic acid-based polymers effective against hepatitis B Virus infection in patients don't harbor immunostimulatory properties in primary isolated liver cellsCatherine Isabell Real, Melanie Werner, Andreas Paul, et al.
Hepatology (Baltimore, Md.)|December 19, 2017
Nucleic acid polymer REP 2139 and nucleos(T)ide analogues act synergistically against chronic hepadnaviral infection in vivo in Pekin ducksJonathan Quinet, Catherine Jamard, Madeleine Burtin, et al.
Journal of Viral Hepatitis|November 20, 2018
Variants of hepatitis B virus surface antigen observed during therapy with nucleic acid polymer REP 2139-Ca have no influence on treatment outcome and its detection by diagnostic assaysHrvoje Mijočević, Hadi Karimzadeh, Judith Seebach, et al.
Virology|November 21, 2007
Inhibition of cellular entry of lymphocytic choriomeningitis virus by amphipathic DNA polymersAndrew M Lee, Jillian M Rojek, Anette Gundersen, et al.
Hepatology Communications|July 17, 2023
Rapid monophasic HBsAg decline during nucleic-acid polymer-based therapy predicts functional cureLeeor Hershkovich, Louis Shekhtman, Michel Bazinet, et al.
Plos One|June 22, 2017
Inhibition of hepatitis B viral entry by nucleic acid polymers in HepaRG cells and primary human hepatocytesClément Guillot, Nora Martel, Françoise Berby, et al.
Antimicrobial Agents and Chemotherapy|May 29, 2008
Amphipathic DNA polymers exhibit antiherpetic activity in vitro and in vivoDavid I Bernstein, Nathalie Goyette, Rhonda Cardin, et al.
Antiviral Research|December 20, 2024
HBV serum RNA kinetics during nucleic acid polymers based therapy predict functional cureLeeor Hershkovich, Scott J Cotler, Louis Shekhtman, et al.
Molecular Therapy. Nucleic Acids|September 18, 2017
Nucleic Acid Polymers with Accelerated Plasma and Tissue Clearance for Chronic Hepatitis B TherapyIngo Roehl, Stephan Seiffert, Celia Brikh, et al.
Journal of Viral Hepatitis|July 20, 2019
Kinetics of hepatitis B surface antigen quasispecies during REP 2139-Ca therapy in HBeAg-positive chronic HBV infectionZainab Usman, Hrvoje Mijočević, Hadi Karimzadeh, et al.
Pageof 6